SIRT1通过PP4酸酶复合体调节DNA损伤信号传递
George Rasti1,2, Maximilian Becker2, Berta N Vazquez1,2
1Chromatin Biology Laboratory, Josep Carreras Leukaemia Research Institute (IJC), Ctra de Can Ruti, Camí de les Escoles s/n, 08916 Badalona, Barcelona, Spain.
Nucleic acids research
|June 13, 2023
概括
SIRT1对抗PP4酸酶复合体,以调节DNA损伤反应途径. 这种相互作用控制了关键的酸化事件,确保了细胞应激期间的基因组稳定性.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 遗传学 是一个遗传学.
背景情况:
- 赛尔图因是依赖NAD+的酶,对于在压力下维持基因组稳定性至关重要.
- 哺乳动物的Sirtuins,包括SIRT1,涉及通过同源重组 (HR) 调节DNA损伤的修复.
- 在DNA损伤反应 (DDR) 中SIRT1的特定作用仍未得到充分研究,尽管SIRT1缺乏会损害DDR并增加基因组不稳定性.
研究的目的:
- 研究SIRT1在DNA损伤反应 (DDR) 中的作用.
- 阐明SIRT1和PP4酸酶复合体在DDR调节中的功能关系.
- 揭示SIRT1影响DNA损伤信号的分子机制.
主要方法:
- 细胞测试用于评估SIRT1缺乏细胞中的DNA损伤反应 (DDR).
- 同免疫沉用于研究SIRT1和PP4复合体子单元之间的蛋白质-蛋白质相互作用.
- 西方涂抹分析关键DDR蛋白的酸化水平,如γH2AX和RPA2.
主要成果:
- 缺少SIRT1的细胞表现出受损的DDR,减少修复能力和增加的基因组不稳定性.
- 在DDR调节中,SIRT1和PP4酸酶复合体之间发现了功能对抗性.
- SIRT1直接与PP4c相互作用,通过脱乙PP4R3α/β子单元来抑制其活性,从而调节γH2AX和RPA2酸化.
结论:
- SIRT1在调节DNA损伤反应 (DDR) 中起着至关重要的作用.
- SIRT1在功能上对抗PP4酸酶复合体,控制关键的DDR信号事件.
- 在压力期间,SIRT1信号提供通过PP4复合体对DNA损伤信号的全球控制,保持基因组稳定性.
相关概念视频
02:37DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
01:23Negative Regulator Molecules
35.5K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
01:20The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
01:22PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
01:38Nucleotide Excision Repair
3.6K
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.6K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K